GL1X · GenesisL1 explorer

Ligand · V97

V97 · N-{5-[4-(2-amino-4-oxo-3,4-dihydrothieno[2,3-d]pyrimidin-6-yl)butyl]thiophene-2-carbonyl}-L-glutamic acid

V97, N-{5-[4-(2-amino-4-oxo-3,4-dihydrothieno[2,3-d]pyrimidin-6-yl)butyl]thiophene-2-carbonyl}-L-glutamic acid (C20 H22 N4 O6 S2, 478.5 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every binding site…

Component
V97
Formula
C20 H22 N4 O6 S2
Class
ligand
Structures
2
PDB entries
1

Binding sites

V97 in 2 structures; the first of them:

  • 7JG0 · Human GAR transformylase in complex with GAR substrate and AGF102 inhibitor · V97 A1102 · binds ASN842, LYS843, HIS864, ARG870, LEU891, PHE894, MET895, ARG896 and 13 more
  • 7JG0 · Human gar transformylase in complex with gar substrate and AGF102 inhibitor · V97 A1102 · binds LYS843, HIS864, ARG870, LEU891, PHE894, MET895, ARG896, ILE897 and 11 more

Residues it binds most

VAL 2, ARG 2, ASP 2, HIS 2, LEU 2, ASN 2, ALA 2, GLU 2, ILE 2, LYS 2 (residue and the binding sites it lines).

Found with

  • GAR · Glycinamide ribonucleotide

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.